1. Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma
   Wei-Ping Zhu et al, 2018, Cell Death Dis CrossRef
2. Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer
   Xiaona Wang et al, 2018, FEBS Open Bio CrossRef
3. Ixazomib promotes CHOP-dependent DR5 induction and apoptosis in colorectal cancer cells
   Dan Yue et al, 2018, Cancer Biology & Therapy CrossRef
4. EBV as a potential risk factor for hepatobiliary system cancer: a meta-analysis with 918 cases
   Zu-xuan Chen et al, 2018, Pathology - Research and Practice CrossRef
5. Cullin-4B E3 ubiquitin ligase mediates Apaf-1 ubiquitination to regulate caspase-9 activity
   Eri Ohta et al, 2019, PLoS ONE CrossRef
6. Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition
   Weiping Zhu et al, 2016, J Hematol Oncol CrossRef
7. TRAIL receptors are differentially regulated and clinically significant in gallbladder cancer
   Deepika Singh et al, 2020, Pathology CrossRef
8. Targeting the Synthetic Vulnerability of PTEN-Deficient Glioblastoma Cells with MCL1 Inhibitors.
   Chao Chen et al, 2020, Mol Cancer Ther CrossRef
9. Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy.
   Deepika Singh et al, 2021, Future Oncol CrossRef
10. TRAIL-induced apoptosis and proteasomal activity – Mechanisms, signalling and interplay
    Chiara Boccellato et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
11. The varicella-zoster virus ORF16 protein promotes both the nuclear transport and the protein abundance of the viral DNA polymerase subunit ORF28
    Huang-Shen Lin et al, 2024, Virus Research CrossRef
12. The Proteasome Inhibitor Marizomib Evokes Endoplasmic Reticulum Stress and Promotes Apoptosis in Human Glioblastoma Cells
    Magdalena Kusaczuk et al, 2024, Pharmaceuticals CrossRef